BREASTSEQ Trademark

Trademark Overview

On Friday, September 19, 2014, a trademark application was filed for BREASTSEQ with the United States Patent and Trademark Office. The USPTO has given the BREASTSEQ trademark a serial number of 86400586. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 26, 2018. This trademark is owned by MED FUSION, LLC. The BREASTSEQ trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical and scientific research in the field of cancer treatment and diagnosis featuring molecular analysis, gene sequencing and tumor profiling for individual cancers; diagnostic testing in the field of molecular analysis, gene sequencing and tumor profiling for individual cancers, for scientific and clinical research purposes

Medical testing for diagnostic and treatment purposes in the field of molecular analysis, gene sequencing and tumor profiling for individual cancers; diagnostic testing in the field of molecular analysis, gene sequencing and tumor profiling for individual cancers, for medical diagnostic and treatment purposes
breastseq

General Information

Serial Number86400586
Word MarkBREASTSEQ
Filing DateFriday, September 19, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 26, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 25, 2015

Trademark Statements

Goods and ServicesMedical and scientific research in the field of cancer treatment and diagnosis featuring molecular analysis, gene sequencing and tumor profiling for individual cancers; diagnostic testing in the field of molecular analysis, gene sequencing and tumor profiling for individual cancers, for scientific and clinical research purposes
Goods and ServicesMedical testing for diagnostic and treatment purposes in the field of molecular analysis, gene sequencing and tumor profiling for individual cancers; diagnostic testing in the field of molecular analysis, gene sequencing and tumor profiling for individual cancers, for medical diagnostic and treatment purposes
Pseudo MarkBREAST SEQ

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 29, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 7, 2015
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMED FUSION, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLewisville, TX 75067
Party NameMED FUSION, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLewisville, TX 75067

Trademark Events

Event DateEvent Description
Monday, November 26, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 26, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 7, 2018EXTENSION 5 GRANTED
Thursday, April 19, 2018EXTENSION 5 FILED
Thursday, April 19, 2018TEAS EXTENSION RECEIVED
Thursday, April 19, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 19, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 19, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, October 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, October 19, 2017EXTENSION 4 GRANTED
Thursday, October 19, 2017EXTENSION 4 FILED
Thursday, October 19, 2017TEAS EXTENSION RECEIVED
Saturday, April 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, April 12, 2017EXTENSION 3 GRANTED
Wednesday, April 12, 2017EXTENSION 3 FILED
Wednesday, April 12, 2017TEAS EXTENSION RECEIVED
Saturday, November 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, November 4, 2016EXTENSION 2 GRANTED
Friday, October 14, 2016EXTENSION 2 FILED
Friday, October 14, 2016TEAS EXTENSION RECEIVED
Tuesday, July 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, July 11, 2016EXTENSION 1 GRANTED
Wednesday, April 20, 2016EXTENSION 1 FILED
Monday, July 11, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 8, 2016NOTICE OF REVIVAL - MAILED
Wednesday, June 8, 2016EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, June 8, 2016PETITION TO REVIVE-GRANTED
Wednesday, June 8, 2016TEAS PETITION TO REVIVE RECEIVED
Monday, May 23, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 23, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 20, 2015NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 25, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 5, 2015NOTICE OF PUBLICATION
Tuesday, July 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 21, 2015ASSIGNED TO LIE
Wednesday, July 8, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 7, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 6, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 6, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 8, 2015PRIORITY ACTION MAILED
Thursday, January 8, 2015PRIORITY ACTION WRITTEN
Monday, January 5, 2015ASSIGNED TO EXAMINER
Tuesday, September 30, 2014NOTICE OF PSEUDO MARK MAILED
Monday, September 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 23, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

breastseq tumor sequencing gene profiling individual diagnostic cancers molecular analysis field